Suzanne Hollander, MS, RD, LDN

home / authors / suzanne-hollander-ms-rd-ldn

Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital.

Articles

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU

Suzanne Hollander, MS, RD, LDN;Timothy Tramontana, MD
July 29th 2025

Suzanne Hollander, MS, RD, LDN; and Timothy Tramontana, MD, offer thoughts on newly FDA-approved sepiapterin for PKU.

PKU and the pediatrician with Suzanne Hollander, MS, RD, LDN

PKU and the pediatrician with Suzanne Hollander, MS, RD, LDN

Suzanne Hollander, MS, RD, LDN
May 8th 2025

In this interview, Suzanne Hollander, MS, RD, LDN, discusses the importance of collaborative care in PKU and the impact of a new potential treatment.

Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's

PKU and sepiapterin data with Suzanne Hollander, MS, RD, LDN

Suzanne Hollander, MS, RD, LDN
May 7th 2025

A review of the clinical potential of PTC Therapeutics' sepiapterin as a novel treatment for phenylketonuria (PKU).

Latest Updated Articles

Published: March 21st 2023 | Updated: November 20th 2024
Guidelines for PUZZLER, Contemporary Pediatrics
Can you diagnose this 11-year-old with a petechial rash? | Image credit: Author provided
Published: July 8th 2025 | Updated: August 13th 2025
Can you diagnose this 11-year-old with a petechial rash?
Puzzler poll: Can you identify this bite?
Published: August 4th 2025 | Updated: August 13th 2025
Puzzler poll: Can you identify this bite?
J&J submits icotrokinra NDA for plaque psoriasis in patients 12 years and up | Image credit: Contemporary Pediatrics
Published: July 21st 2025 | Updated: August 13th 2025
J&J submits icotrokinra NDA for plaque psoriasis in patients 12 years or older
Study: Daily emollient for infants could reduce atopic dermatitis incidence | Image credit: stock.adobe.com.
Published: July 28th 2025 | Updated: August 13th 2025
Study: Daily emollient for infants could reduce atopic dermatitis incidence
FDA grants fast track to rezpegaldesleukin for severe alopecia areata in ages 12 and up | Image credit: Contemporary Pediatrics
Published: July 29th 2025 | Updated: August 13th 2025
FDA grants fast track designation to rezpegaldesleukin for severe alopecia areata in patients 12 years or older
© 2025 MJH Life Sciences

All rights reserved.